| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0001 | 1 |